 One study modeled that, in the US, the average yearly cost of biological therapy for inflammatory bowel disease was around $36,000.The treatment of inflammatory bowel diseases, with an estimated direct cost of $5.9 billion annually, poses a significant economic burden on the health care system.Recently, the primary treatment cost has shifted from hospitalization to medication.